Last updated on October 2018

Rainbow Extension Study


Brief description of study

The purpose of this study is to evaluate the long term efficacy and safety of intravitreal ranibizumab compared with laser ablation therapy in patients who were treated for retinopathy of prematurity (ROP) in the core study CRFB002H2301

Clinical Study Identifier: NCT02640664

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Zentsuji-city, Japan
9.32miles
  Connect »